Biotech

All Articles

Otsuka pays out $800M for Jnana as well as its clinical-stage PKU medication

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Rehabs for $800 million so the Oriental biotec...

FibroGen gives up 75% people personnel as property fails 2 additional trials

.FibroGen is drastically reorganizing its own service, laying off 75% of its own united state staff ...

Tracon unwind weeks after injectable PD-L1 prevention neglect

.Tracon Pharmaceuticals has actually made a decision to relax procedures weeks after an injectable i...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on stopped working epilepsy medication, touts FDA manage

.We already recognize that Takeda is actually expecting to find a pathway to the FDA for epilepsy me...

VBI Injections declare insolvency, finds possession sale

.Immunology biotech VBI Injections is turning alarmingly close to the climax, with plans to declare ...

Celldex anti-cKIT antitoxin lessen hives in one more phase 2 study

.It is actually hard to muscle in on a room as affordable as immunology, yet Celldex Therapies feels...

Boehringer provides to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Rehabs and a preclinical imm...

Ventyx's last resort for inflammatory med ends in Crohn's breakdown

.Ventyx Biosciences' Crohn's illness medication performed certainly not help patients obtain remissi...

Cognition's phase 2 radiate data taint Alzheimer's prospect

.Knowledge Therapeutics' phase 2 luster test has taken a number of the appeal off the Alzheimer's he...